Clinical trial
Multicenter Prospective Randomized Controlled Study of Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone in the Treatment of pN1-2 (pT1b-3N1-2M0) Thoracic Esophageal Squamous Cell Carcinoma
NCT04009265 is registered in ClinicalTrials.gov with Fujian Medical University Union Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Prospective Randomized Controlled Study of Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone in the Treatment of pN1-2 (pT1b-3N1-2M0) Thoracic Esophageal Squamous Cell Carcinoma
- Lead sponsor
- Fujian Medical University Union Hospital
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- August 23, 2019
- Completion date
- July 1, 2027
- Enrollment
- 819 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.